Patents by Inventor Ian Wilding

Ian Wilding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140044786
    Abstract: An orally deliverable pharmaceutical composition provides controlled release of aripiprazole. The composition includes a therapeutically effective amount of aripiprazole and at least one pharmaceutically acceptable excipient. The compositions of the invention may exhibit one or more of the release profiles defined in the specification.
    Type: Application
    Filed: October 14, 2013
    Publication date: February 13, 2014
    Applicant: ZYSIS LIMITED
    Inventors: Ian WILDING, Russell PENDLETON
  • Patent number: 8575172
    Abstract: An orally deliverable pharmaceutical composition provides controlled release of aripiprazole. The composition includes a therapeutically effective amount of aripiprazole and at least one pharmaceutically acceptable excipient. The compositions of the invention may exhibit one or more of the release profiles defined in the specification.
    Type: Grant
    Filed: September 26, 2007
    Date of Patent: November 5, 2013
    Assignee: Zysis Limited
    Inventors: Ian Wilding, Russell Pendleton
  • Publication number: 20100104643
    Abstract: The present invention provides an orally deliverable pharmaceutical composition for the once-daily (OD) administration of trimipramine. The composition comprises a therapeutically effective amount of trimipramine and at least one pharmaceutically acceptable excipient. The compositions of the invention may exhibit one or more of the release profiles defined in this specification.
    Type: Application
    Filed: April 14, 2008
    Publication date: April 29, 2010
    Applicant: ZYSIS LIMITED
    Inventors: Ian Wilding, Russell Pendleton
  • Publication number: 20100004262
    Abstract: An orally deliverable pharmaceutical composition provides controlled release of aripiprazole. The composition includes a therapeutically effective amount of aripiprazole and at least one pharmaceutically acceptable excipient. The compositions of the invention may exhibit one or more of the release profiles defined in the specification.
    Type: Application
    Filed: September 26, 2007
    Publication date: January 7, 2010
    Applicant: ZYSIS LIMITED
    Inventors: Ian Wilding, Russell Pendleton
  • Publication number: 20070270630
    Abstract: An ingestible device for delivering a substance to a chosen location in the GI tract of a mammal includes a receiver of electromagnetic radiation for powering an openable part of the device to an opened position for dispensing of the substance. The receiver includes a coiled wire that couples the energy field, the wire having an air or ferrite core. In a further embodiment the invention includes an apparatus for generating the electromagnetic radiation, the apparatus including one or more pairs of field coils supported in a housing. The device optionally includes a latch defined by a heating resistor and a fusible restraint. The device may also include a flexible member that may serve one or both the functions of activating a transmitter circuit to indicate dispensing of the substance; and restraining of a piston used for expelling the substance.
    Type: Application
    Filed: July 30, 2007
    Publication date: November 22, 2007
    Inventors: Peter Houzego, Peter Morgan, Peter Hirst, Duncan Westland, Ian Wilding
  • Publication number: 20050075559
    Abstract: An ingestible device for delivering a substance to a chosen location in the GI tract of a mammal includes a receiver of electromagnetic radiation for powering an openable part of the device to an opened position for dispensing of the substance. The receiver includes a coiled wire that couples the energy field, the wire having an air or ferrite core. In a further embodiment the invention includes an apparatus for generating the electromagnetic radiation, the apparatus including one or more pairs of field coils supported in a housing. The device optionally includes a latch defined by a heating resistor and a fusible restraint. The device may also include a flexible member that may serve one or both the functions of activating a transmitter circuit to indicate dispensing of the substance; and restraining of a piston used for expelling the substance.
    Type: Application
    Filed: June 27, 2003
    Publication date: April 7, 2005
    Inventors: Peter Houzego, Peter Morgan, Peter Hirst, Duncan Westland, Ian Wilding
  • Patent number: 6592020
    Abstract: The invention relates to a lead-free solder paste comprising a solder paste flux and solder alloy particles that are substantially lead-free wherein the solder paste flux comprises resin dissolved in a solvent and also includes undissolved resin particles less than 25 &mgr;m in size homogenously dispersed therein to provide improved solder alloy powder coalescence and substrate surface wetting while maintaining appropriate solder paste rheology for use in printed circuit board assembly processes.
    Type: Grant
    Filed: October 17, 2001
    Date of Patent: July 15, 2003
    Assignee: Henkel Loctite Adhesives Limited
    Inventors: Mark Currie, Angelo Elyassi, Grahame Freeman, Malcolm Warwick, Ian Wilding
  • Patent number: 5407682
    Abstract: Azo-and/or disulfide-containing polymers for use as drug delivery systems having site-specific release of the drug in the colon are obtained by polycondensation or polyaddition of an azo- and/or polysulfide disulfide containing a, w-dihydroxy or diamino reagent with a suitable a, w-difunctional dicarboxylic acid; disocyanato-, disulfide comonomer. The resulting reduction sensitive polymers are linear macromolecules containing an azo and/or a disulfide bond in their polymer backbone.
    Type: Grant
    Filed: September 9, 1992
    Date of Patent: April 18, 1995
    Assignee: Danbiosyst UK Ltd Aisha
    Inventors: Etienne Schacht, Ian Wilding